Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.52M Buy
19,944
+5,099
+34% +$2.07M 2.54% 17
2026
Q1
$5.02M Buy
+14,845
New +$5.11M 2.41% 19
2024
Q3
Sell
-8,850
Closed -$1.54M 83
2024
Q2
$1.54M Buy
+8,850
New +$1.34M 0.63% 41
2023
Q3
Sell
-7,055
Closed -$712K 81
2023
Q2
$712K Buy
+7,055
New +$657K 0.46% 44
2021
Q1
Sell
-7,540
Closed -$822K 101
2020
Q4
$822K Buy
7,540
+3,500
+87% +$332K 0.43% 54
2020
Q3
$328K Buy
+4,040
New +$307K 0.2% 72

Other funds holding TSM

Geneva Partners's TSM Position: Q2 2026 in Review

Geneva Partners increased its TSMC (TSM) stake by 34% in Q2 2026, buying an estimated $2.07M and bringing the position to 19,944 shares worth $9.52M. The position accounts for 2.54% of the portfolio, ranked #17.

Geneva Partners first reported a position in TSM in Q3 2020 and has held it in 6 quarters since. 3,578 funds tracked by Wall St. Rank hold TSM as of Q2 2026.

  • Geneva Partners held 19,944 shares of TSMC worth $9.52M as of Q2 2026.
  • Geneva Partners bought 5,099 TSMC shares in Q2 2026, an estimated $2.07M.
  • TSMC made up 2.54% of Geneva Partners's portfolio in Q2 2026, its #17 holding.
  • Geneva Partners first reported a position in TSMC in Q3 2020 and has held it in 6 quarters since.
  • 3,578 funds tracked by Wall St. Rank held TSMC as of Q2 2026.

Based on Geneva Partners's 13F filing for Q2 2026, filed 10 Aug 2026.